We can’t show the full text here under this license.
Abstract
A 61-year-old woman developed euglycaemic ketoacidosis after six weeks of tirzepatide therapy for weight loss.
- Euglycaemic ketoacidosis occurred despite the patient having normal blood glucose levels.
- The patient showed significant ketonaemia and metabolic acidosis during the episode.
- Resolution of the condition was achieved with intravenous fluid resuscitation and replacement.
- This case highlights the need for awareness of potential adverse effects associated with tirzepatide.
- It raises concerns regarding the safety of prescribing tirzepatide through online consultations with less monitoring.
Simplified